Researchers use genetically engineered immune cells to put a child's metastatic cancer into remission
SMRTR summary
A young boy with liver cancer that spread to his lungs was treated with CAR-T cell therapy after chemotherapy failed. Doctors genetically engineered his own immune cells to target the cancer, and after two doses, scans confirmed full remission. Twelve months later, he remains cancer-free.
SMRTR provides this summary for quick context. The original article belongs to TechSpot.
Read the original article